While Altimmune Inc has overperformed by 0.49%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, ALT rose by 134.10%, with highs and lows ranging from $14.84 to $2.09, whereas the simple moving average jumped by 83.59% in the last 200 days.
On January 24, 2024, Goldman started tracking Altimmune Inc (NASDAQ: ALT) recommending Neutral. A report published by Goldman on March 22, 2023, Downgraded its rating to ‘Neutral’ for ALT. Goldman also rated ALT shares as ‘Buy’, setting a target price of $20 on the company’s shares in an initiating report dated December 01, 2022. Jefferies Initiated an Buy rating on December 29, 2021, and assigned a price target of $30. H.C. Wainwright initiated its ‘Buy’ rating for ALT, as published in its report on June 02, 2021. Guggenheim’s report from February 11, 2021 suggests a price prediction of $36 for ALT shares, giving the stock a ‘Buy’ rating. Jefferies also rated the stock as ‘Buy’.
Analysis of Altimmune Inc (ALT)
Further, the quarter-over-quarter increase in sales is 133.64%, showing a positive trend in the upcoming months.
One of the most important indicators of Altimmune Inc’s future performance is equity, which can be evaluated using several well-rounded types of analysis and research techniques. The goal here is to ensure that your current return on equity of -46.63% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 17.25, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
For any stock, average volume can also provide valuable insight into volatility, and ALT is recording 6.12M average volume. On a monthly basis, the volatility of the stock is set at 9.71%, whereas on a weekly basis, it is put at 13.41%, with a gain of 12.67% over the past seven days. Furthermore, long-term investors anticipate a median target price of $22.00, showing growth from the present price of $10.23, which can serve as yet another indication of whether ALT is worth investing in or should be passed over.
How Do You Analyze Altimmune Inc Shares?
Along with the fundamentals, it is also important to consider how many employees own shares of the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 1.02%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 67.61% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
ALT shares are owned by institutional investors to the tune of 67.61% at present.
